Airway Protective Mechanisms in PD (R01)

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

July 29, 2023

Study Completion Date

September 29, 2023

Conditions
Parkinson Disease
Interventions
DRUG

Capsaicin

Participants will inhale aerosolized capsaicin with the goal of this inducing cough and an urge-to-cough.

DEVICE

Resistive respiratory loads

Participants will breath through a mouthpiece. Every 3-5 breaths in, a respiratory load will be applied. Participants will be asked to rate the magnitude of the load.

OTHER

Event-related evoked potential using electroencephalography (EEG).

The study team will use EEG time-locked to a respiratory occlusion to measure the brain's response to respiratory sensation.

PROCEDURE

Fluoroscopic swallow evaluation

Participants will swallow various consistencies of barium under fluoroscopy (moving-picture x-ray) in order to assess swallowing safety and efficiency.

Trial Locations (1)

32611

University of Florida Center for Movement Disorders and Neurorestoration, Gainesville

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Florida

OTHER

NCT03321019 - Airway Protective Mechanisms in PD (R01) | Biotech Hunter | Biotech Hunter